Two master’s students from Ghent University are conducting a thesis project on the development of a generic risk stratification tool for cardiovascular complications resulting from oncological treatments.
The aim is to create a tool that can be applied regardless of cancer type or treatment modality and that will be validated by healthcare professionals from clinical practice. To achieve this, a two-round Delphi study is being conducted, in which participants will complete two online questionnaires.
Data are collected pseudonymously via Qualtrics®, with strict attention to participant confidentiality. Participation is voluntary and can be discontinued at any time.
👉 Link to the first Delphi questionnaire (available in English, Dutch, and French):
Delphi Survey – Risk of Cardiotoxicity in Oncology Treatments
